Science, Computers & Technology Antitrust & Trade Regulation Elections & Politics

FTC Cybersecurity Consumer Privacy Bill of Rights Proposed Legislation Barack Obama Obama Administration Data Protection Legislative Agendas Popular Pending Legislation Personally Identifiable Information Data Breach Pharmaceutical Industry Breach Notification Rule Covered Entities Data Security Discussion Draft DOJ Enforcement Actions Federal Breach Notification Standard Prescription Drugs Student Digital Privacy Act Affordable Care Act Biologics Competition Congressional Investigations & Hearings Drug Pricing EU Generic Drugs Gramm-Leach-Blilely Act Health Care Providers HIPAA Information Sharing Medicaid National Security Presidential Elections Safe Harbors Target Trans-Pacific Partnership Biosimilars China Civil Monetary Penalty CJEU Class Action CMS Corporate Counsel Cyber Attacks Cybersecurity Framework Data Brokers Data Privacy Data Security and Breach Notification Act of 2015 Enforcement EU-US Privacy Shield Executive Orders FCC FDA FTC Act GAO Hackers Healthcare Healthcare Reform HHS International Data Transfers LabMD NIST NSA Patent Reform Patent Trolls Patents Pharmaceutical Patents Price Transparency Privacy Laws Privacy Policy Security and Privacy Controls State of the Union Telehealth ACA Acquisitions Administrative Hearings Administrative Procedure Act Aerospace America Invents Act American Medical Association AMP v Myriad Anti-Competitive Anti-Kickback Statute Antitrust Litigation APHIS Attorney Generals Aurobindo Pharmaceuticals Australia Ballot Measures Banking Sector Big Data CFPB CFTC CHIP Citron Pharmaceuticals Code of Conduct Communications Act of 1934 Computer Fraud and Abuse Act (CFAA) COPPA Copyright Cost-Sharing Critical Infrastructure Sectors Customs and Border Protection Cyber Threats Data Collection Data Theft Defense Sector Delta Airlines Department of Transportation (DOT) DHS DNA Donald Trump E-Cigarettes Edith Ramirez Energy Sector Enforcement Authority Exclusive Dealing Agreements Exclusivity Clauses False Claims Act (FCA) Federal Aviation Administration (FAA) Federal Funding Fee-for-Service Final Rules Foreclosure Foreign Relations FRAND FTC v Actavis Genetic Materials Gilead Sciences Google Governor Baker Health Information Technologies Health Insurance Healthcare Costs Hillary Clinton Hospice Huawei Human Genes Identity Theft Injunctive Relief Innovation Act Intellectual Property Protection Internet IPAB ISAOs ISIS Legislative Committees Leniency Programs Licensing Rules Mayne Pharmaceuticals MCOs Medicare Medicare Part D Mergers Mobile Apps Multidistrict Litigation Mylan Pharmaceuticals Myriad Neiman Marcus New Legislation Non-Discrimination Rules Nurse Practitioners OCC OCR OIG Pay-For-Delay Performance Improvement Plans Personal Data Notification and Protection Act Pharmacies PHRMA Planned Parenthood Political Campaigns Political Debates Preemption Presidential Directives Price-Fixing PRISM Privacy Concerns Product Exclusivity Proposed Regulation Public Health Public Schools Ransomware Rebuttable Presumptions Registration Requirement Reimbursements REMS Research and Development Reverse Payment Settlement Agreements Risk Management Risk Mitigation Sanctions Sandoz v Amgen School Districts SCOTUS SEC Section 5 Senate Judiciary Committee Settlement Agreements Small Business Social Security Act Sony Student Privacy Students Substance Abuse Surveillance TCPA Technology Telecommunications Telemarketing Telemedicine Teva Pharmaceuticals Trade Agreements Trademarks Trump Administration TSA U.S. Commerce Department UK Brexit Unfair or Deceptive Trade Practices United Airlines Unmanned Aircraft Systems US-EU Safe Harbor Framework Value-Based Payments Watson Pharmaceuticals WhatsApp ZTE